Stock Events

Stock Events

Search...

MoonLake Immunotherapeutics (MLTX) Q4 2024 Earnings

7NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.56

-0.41

-0.27

-0.12

Details

Expected EPS

-0.435472

Actual EPS

-0.56

Surprise EPS

-0.12

Surprise Percent

+28.6%

Description

MoonLake Immunotherapeutics (MLTX) has reported earnings of -0.56 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.